A missense variant p.R658C of BARD1 was detected in 39 (0.68%) unselected prostate cancer cases compared to 61 (0.60%) cancer-free controls (OR = 1.15, p = 0.57). This evidence concerns the gene BARD1 and prostate carcinoma.